Early initiation of sodium‐glucose linked transporter inhibitors (SGLT‐2i) and associated metabolic and electrolyte outcomes in diabetic kidney transplant recipients

There is a paucity of data on the use of SGLT2 inhibitors on outcomes in kidney transplant recipients. There may be concern in initiating these agents, especially within the first year post‐transplant when renal function is more labile and immunosuppression more intense, due to a presumed high risk...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Endocrinol Diabetes Metab
Hlavní autoři: Song, Chelsey Chenxi, Brown, Andrew, Winstead, Ryan, Yakubu, Idris, Demehin, Moses, Kumar, Dhiren, Gupta, Gaurav
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8029504/
https://ncbi.nlm.nih.gov/pubmed/33855198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.185
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky